Search

Filters

Clear Filters
8:30 AM - 8:35 AM ET

1216 - Impact of Staging Laparoscopy on Tumor Control and Survival Comparison in Locally Advanced Gastric Cancer after Preoperative Chemoradiation vs. Preoperative Chemotherapy: Data from the Neo-CRAG Phase III Clinical Trial
Speaker: Zhang, Yu-Jing, MD, PhD -
8:05 AM - 8:10 AM ET

1217 - Eugonadal Progression-Free Survival Following Intensification of Metastasis-Directed Stereotactic Body Radiotherapy with Radioligand Therapy or Androgen Annihilation Therapy: A Comparison of Two Phase II Trials
Speaker: Yu, Esther, MD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles, CA
8:10 AM - 8:15 AM ET

1218 - Outcomes of Risk-Stratified and Intensified Salvage Re-Irradiation in Local Recurrence : A Prospective Cohort Comparison
Speaker: Belliveau, Colin, MD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, QC
8:15 AM - 8:20 AM ET

1219 - Stereotactic Prostate Cancer Ablative RE-Irradiation: A Systematic Review and Meta-Analysis (SPARE)
Speaker: Gouveia, Andre, MD, MBA - McMaster University, Hamilton, On
3:10 PM - 3:20 PM ET

122 - <sup>64</sup>cu-Anti-CEA M5A PET Imaging Pre and Post Neoadjuvant Radiotherapy In Advanced Rectal Cancer
Speaker: Wong, Jeffrey, MD, FASTRO - City of Hope National Medical Center, Duarte, CA
8:20 AM - 8:25 AM ET

1220 - Salvage High-Dose-Rate Brachytherapy after Prior Prostate Radiotherapy: Contemporary Multi-Institutional Outcomes in 236 Patients
Speaker: Bilski, Mateusz, MD, PhD - Lublin Region Oncology Center, Lublin
8:25 AM - 8:30 AM ET

1221 - MRI-Guided Risk-Adaptive High Dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: A Phase II Trial
Speaker: Thomsen, Bryce, MD - Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA
8:30 AM - 8:35 AM ET

1222 - A Prospective Single-Arm Study of POSLUMA PET in Very Low Prostate-Specific Antigen Recurrence Following Prostatectomy
Speaker: Hogan, Jacob, MD - Harvard Radiation Oncology Program, Boston, MA
8:05 AM - 8:10 AM ET

1223 - Impact of Risk of New-Lesion Progression on Benefit of Local Consolidative Therapy in Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer
Speaker: Chen, Hongru - Fudan University Shanghai Cancer Center, Shanghai, DC
8:10 AM - 8:15 AM ET

1224 - Role of Consolidation Radiotherapy in Mutation-Positive vs. Mutation-Negative Patients with Stage 4 Oligopersistent NSCLC
Speaker: Ray, Amitabh, MD, MBBS, DNB - CNCI, Kolkata, West Benga
8:15 AM - 8:20 AM ET

1225 - Are Some "New" Lung Metastases Already Present at Baseline? An Artificial Intelligence-Based Re-evaluation in Patients Undergoing Lung SBRT for Oligometastases
Speaker: Ko, Heejoo, MD, BS - College of Medicine, The Catholic University of Korea, Seoul, SEO
8:20 AM - 8:25 AM ET

1226 - Feasibility of Aumolertinib followed by SRT in EGFR+ NSCLC Patients with Intracranial Oligo-Progression: A Phase II, Prospective Study
Speaker: Chen, Jiayan, MD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai